What Is Oncofertility Care?

Fertility Support During Cancer Care

A cancer diagnosis can make the future feel suddenly uncertain. For patients who may want children someday, one of the most important questions is also one of the easiest to miss in the rush of treatment planning: how could cancer treatment affect fertility and reproductive health?

Oncofertility care exists to bring that question into the open. It is an interdisciplinary approach that connects oncology and reproductive medicine so patients can understand fertility risks, preservation options, and hormone-related concerns before, during, and after cancer treatment. A 2018 Pediatric Blood & Cancer review on oncofertility as an emerging discipline describes oncofertility as care that involves both cancer and fertility health care providers, including risk counseling, fertility preservation options, and support for reproductive health complications.

At its best, oncofertility is not a side conversation. It is part of whole-person cancer care, especially for adolescents, young adults, and reproductive-age patients whose future family-building goals may be affected by chemotherapy, radiation, surgery, or hormonal treatment.

Why Timing Matters

Cancer treatment can affect fertility in different ways depending on the diagnosis, treatment type, dose, age, baseline reproductive health, and whether the ovaries, testes, uterus, or hormone-regulating systems are directly involved. Some people may keep reproductive potential after treatment. Others may face temporary or permanent infertility, early menopause, hormonal deficiency, menstrual changes, or sexual health concerns.

Because many fertility preservation choices are time-sensitive, the ideal moment for a conversation is often before treatment begins. That does not mean every patient will choose preservation, or that every option will be medically appropriate. It means patients deserve enough information to understand what is at stake and what choices may be available.

This is one reason early referral matters. The same PMC review’s section on fertility specialist referral notes that reproductive-age patients receiving curative treatment should receive reliable information about reproductive harm risk and potential fertility preservation options, with specialist referral when individualized assessment is needed.

What Oncofertility Care May Include

Oncofertility care is broader than egg freezing alone. Depending on the patient, diagnosis, age, timeline, and treatment plan, care may include:

• Fertility risk assessment before cancer treatment
• Egg freezing, also called oocyte cryopreservation
• Embryo freezing for patients who want to fertilize eggs before storage
• Sperm banking for post-pubertal male patients
• Ovarian tissue cryopreservation in selected settings
• Testicular tissue cryopreservation or biopsy in highly specialized or research-based settings
• Ovarian transposition before certain pelvic radiation treatments
• Hormonal and menstrual health management during or after treatment
• Sexual health support, survivorship care, and emotional counseling

According to the same review’s discussion of established and experimental fertility preservation options, oocyte, embryo, and sperm cryopreservation are established methods in many settings. Other options may depend more heavily on age, cancer type, available time before treatment, local expertise, and whether a center offers a procedure as standard care or within a research framework. For a broader look at preservation logistics, Her Serenity’s guide to what to expect during the fertility preservation process may help explain how planning, appointments, and timing can fit together.

A Team-Based Model

Oncofertility works best when care teams communicate clearly. An oncologist may understand the urgency and risks of cancer treatment, while a reproductive endocrinologist can explain preservation options, ovarian or sperm-related testing, and what may be realistic within the available timeline. Nurses, mental health professionals, genetic counselors, social workers, and patient navigators may also play important roles.

This team-based approach matters because patients are often making decisions under emotional pressure. A fertility preservation choice may involve medical risk, cost, timing, values, future relationships, ethical questions, and uncertainty. No patient should have to piece that together alone.

For patients with breast cancer, timing and hormone sensitivity can add another layer to the discussion. Our article on why early fertility conversations matter after a breast cancer diagnosis explores that issue in more detail.

Patient Autonomy Comes First

A core principle of oncofertility care is autonomy. Patients should be able to make informed decisions based on their medical reality, personal values, culture, relationships, finances, and future hopes.

That also means there is no single “right” answer. One patient may want to pursue egg or embryo freezing before treatment. Another may decide not to delay cancer treatment for preservation. Someone else may need time to process whether future biological parenthood matters to them. For adolescents and young adults, parents or guardians may be involved, but the patient’s voice still deserves respect in age-appropriate ways.

The source review emphasizes that fertility preservation decisions can be complex, value-laden, uncertain, and often rushed before cancer treatment. That is exactly why oncofertility care should make space for clear information, emotional support, and shared decision-making instead of pressure.

Questions Patients Can Ask

If you or someone you love is facing cancer treatment, these questions may help start the conversation:

• How could my specific treatment plan affect fertility or hormone health?
• Do I have time to consider fertility preservation before treatment starts?
• Which preservation options are medically appropriate for me?
• Could any option delay cancer treatment, and if so, by how much?
• Are there special concerns related to my cancer type or medications?
• What costs, insurance coverage, or financial assistance should I understand?
• Who will coordinate communication between oncology and fertility care?
• What reproductive health follow-up should I receive after treatment?

These questions are not about adding pressure during an already difficult time. They are about making sure patients are not left wishing the conversation had happened earlier.

How This Connects to Her Serenity

Here at Her Serenity, we believe every patient deserves compassionate guidance, access to fertility preservation options, and the ability to make informed choices about their reproductive future with confidence and support.

Oncofertility care reflects that belief. It recognizes that cancer treatment is not only about survival, but also about quality of life, identity, hormones, sexuality, future family-building, and emotional wellbeing. Whether a patient is considering preservation before treatment or exploring family-building after cancer, support should feel informed, respectful, and deeply personal.

For patients looking ahead after treatment, our article on building a family after cancer and what research says about IVF outcomes offers another supportive next step.